Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Semaglutide 2.4 mg (Wegovy) has shown robust weight loss in primary obesity trials, with mean weight reductions of 14.9% in the STEP 1 trial published in the New England Journal of Medicine (2021)
35 Physical function assessment included hand grip test, 30-second chair stand test, 8-ft time up and go test, 2-minute step test, gait speed test at rapid pace, peak expiratory flow rate (PEFR) test, and shoulder strength test
November 10, 2023
503A vs 503B at a glance Can you still get compounded tirzepatide in 2026
US$ 26.28
US$ 29.89
US$ 27.81
